TORONTO, June 6, 2023 /CNW/ - CareRx Corporation ("CareRx" or the "Company") (TSX: CRRX), Canada's leading provider of pharmacy services to seniors living and other congregate care communities, today announced that the nominees listed in the Management Information Circular for the Annual General Meeting of Shareholders (the "Meeting"), which was held on June 6, 2023, were elected as directors of the Company. In addition, all other resolutions put to vote at the Meeting were passed.
Puneet Khanna, CareRx's newly appointed President and CEO, and Jeff Watson, former CEO of Apotex Inc., join the Board as directors.
"On behalf of the Board of Directors, we are pleased to welcome Puneet and Jeff to the CareRx Board," said Kevin Dalton, Chairman of CareRx. "The Board has the utmost confidence in Puneet's ability to guide the Company through its next phase of its long-term growth journey. Additionally, we are excited to have Jeff join as a new director, bringing fresh perspectives and invaluable expertise. Finally, I would like to extend the Board's sincere gratitude to Matt Hills, who did not stand for re-election. Matt served as director for four years and contributed greatly to our success."
The results of the vote for the election of directors at the Meeting are as follows:
Nominees Votes For Kevin Dalton 31,231,195 (99.535 %) Ralph Desando 30,857,453 (98.344 %) Puneet Khanna 31,242,017 (99.569 %) Keith McIntosh 30,916,187 (98.531 %) Bruce Moody 31,167,057 (99.330 %) Maria Perrella 31,300,640 (99.756 %) Jeff Watson 31,303,702 (99.766 %)
About CareRx Corporation
CareRx is Canada's leading provider of pharmacy services to seniors living communities. We serve over 94,000 residents in over 1,600 seniors and other congregate care communities (long-term care homes, retirement homes, assisted living facilities, and group homes). We are a national organization with a large network of pharmacy fulfillment centres strategically located across the country. This allows us to deliver medications in a timely and cost-effective manner and quickly respond to routine changes in medication management. We use best-in-class technology that automates the preparation and verification of multi-dose compliance packaging of medication, providing the highest levels of safety and adherence for individuals with complex medication regimes. We take an active role in working with our home operator partners to promote resident health, staff education, and medication system quality and efficiency.
SOURCE CareRX Corporation Cision
View original content: http://www.newswire.ca/en/releases/archive/June2023/06/c6866.html
CareRx Reports Voting Results from Annual General Meeting of Shareholders
You are reading a free article with opinions that may differ from the recommendation given by Kalkine in its paid research reports. Become a Kalkine member today to get access to our research reports, in-depth technical and fundamental research.
Start Your Free Trial Now!Not sure where to invest today?
Kalkine’s latest research highlights three companies identified through in-depth analysis and market insights.
Explore these research reports to learn about companies currently being tracked by our analysts and make more informed investment decisions.
View 3 Research ReportsThis information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on ‘as is’ basis, using their API. The information and data provided on this page, as well as via the API, are not guaranteed to be real-time or accurate. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general informational purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine does not assume any responsibility for any trading losses you might incur as a result of using this information, data, or any analyst rating or recommendation provided. Kalkine will not accept any liability for any loss or damage resulting from reliance on the information, including but not limited to data, quotes, charts, analyst ratings, recommendations, and buy/sell signals sourced via the API.
Please be fully informed about the risks and costs associated with trading in the financial markets, as it is one of the riskiest forms of investment. Kalkine does not provide any warranties regarding the information on this page, including, without limitation, warranties of merchantability or fitness for a particular purpose or use.
Please wait processing your request...